Eli Lilly's (LLY) Latest Mounjaro Efficacy Data "Unmatched", Analyst Sees More Upside, Reiterates Stock as Top Pick - Mizuho Securities Bullish with $365 Price Target
Tweet Send to a Friend
Mizuho Securities analyst Vamil Divan reiterated a Buy rating and $356.00 price target on Eli Lilly (NYSE: LLY), following the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
